"Jarkovsk\u00FD, Ji\u0159\u00ED" . . "Dynamika hladiny interleukinu 6 u pacient\u016F v septick\u00E9m a kardiogenn\u00EDm \u0161oku a u pacient\u016F s akutn\u00EDm infarktem myokardu s elevacemi ST" . "P\u00E1vkov\u00E1 Goldbergov\u00E1, Monika" . . . "P(ED1.100/02/0123), S" . . "Mich\u00E1lek, Jaroslav" . "Hel\u00E1nov\u00E1, Kate\u0159ina" . "cardiogenic shock; interleukin 6; myocardial infarction; predictor; prognostic; septic shock"@en . "Litzman, Ji\u0159\u00ED" . . . . . . . "0042-773X" . "Mal\u00E1ska, Jan" . . . . "Kubkov\u00E1, Lenka" . . "Dynamika hladiny interleukinu 6 u pacient\u016F v septick\u00E9m a kardiogenn\u00EDm \u0161oku a u pacient\u016F s akutn\u00EDm infarktem myokardu s elevacemi ST"@cs . "60" . "\u00DAvod: Kardiogenn\u00ED \u0161ok (KS) je hlavn\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED pacient\u016F hospitalizovan\u00FDch pro akutn\u00ED infarkt myokardu. V r\u00E1mci akutn\u00EDho infarktu myokardu a kardiogenn\u00EDho \u0161oku byl pozorov\u00E1n rozvoj z\u00E1n\u011Btliv\u00E9 odpov\u011Bdi. C\u00EDlem na\u0161i pr\u00E1ce bylo popsat dynamiku interleukin 6 (IL6) u pacient\u016F v kardiogenn\u00EDm \u0161oku a porovnat ji s dynamikou inter-leukinu 6 u pacient\u016F v septick\u00E9m \u0161oku (S\u0160) a kontroln\u00ED skupinou pacient\u016F s nekomplikovan\u00FDm akutn\u00EDm infarktem myokardu s elevacemi ST (STEMI) a vyhodnotit jeho diagnostick\u00E9 a prognostick\u00E9 mo\u017Enosti. Metodika a pacienti: V prospektivn\u00ED observa\u010Dn\u00ED studii bylo za\u0159azeno celkem 71 pacient\u016F, kte\u0159\u00ED splnili za\u0159azovac\u00ED krit\u00E9ria: 30 pacient\u016F v kardiogenn\u00EDm \u0161oku, 21 pacient\u016F v septick\u00E9m \u0161oku a 20 pacient\u016F se STEMI. Hladiny IL6 byly stanoveny celkem Skr\u00E1t po dobu 3 m\u011Bs\u00EDc\u016F. Hlavn\u00EDm sledovan\u00FDm parametrem byla Sm\u00E9s\u00ED\u010Dn\u00ED mortalita. V\u00FDsledky: Nejvy\u0161\u0161\u00ED hodnoty IL6 byly detekov\u00E1ny v pr\u016Fb\u011Bhu 1. t\u00FDdne u pacient\u016F v septick\u00E9m \u0161oku s maxim\u00E1ln\u00ED hodnotou p\u0159i p\u0159ijet\u00ED."@cs . . "G\u00E1l, Roman" . "Pa\u0159enica, Ji\u0159\u00ED" . "CZ - \u010Cesk\u00E1 republika" . . "Dynamika hladiny interleukinu 6 u pacient\u016F v septick\u00E9m a kardiogenn\u00EDm \u0161oku a u pacient\u016F s akutn\u00EDm infarktem myokardu s elevacemi ST"@cs . "RIV/00216224:14110/14:00079379!RIV15-MSM-14110___" . . "\u010Cerm\u00E1kov\u00E1, Zde\u0148ka" . "Veselkov\u00E1, Zuzana" . . "12753" . "Dynamika hladiny interleukinu 6 u pacient\u016F v septick\u00E9m a kardiogenn\u00EDm \u0161oku a u pacient\u016F s akutn\u00EDm infarktem myokardu s elevacemi ST" . "14"^^ . "Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI"@en . . "\u0160pinar, Jind\u0159ich" . "9"^^ . "14110" . "15"^^ . . . . "Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI"@en . "\u0160ev\u010D\u00EDk, Pavel" . . . "Introduction: Cardiogenic shock (CS) is the leading cause of mortality in patients with acute myocardial infarction (AMI). Inflammatory response seems to be common response in patients with AMI, especially those with CS. We have therefore conducted a study to determine diagnostic and prognostic utility of interleukin 6 (IL6) levels in the cohort of patients with cardiogenic and septic shock (SS) and in a control group of patients with uncomplicated AMI. Methods: In this prospective study 71 patients fulfilled the inclusion criteria: 30 patients with cardiogenic shock, 21 patients with septic shock and 20 patients with ST elevation myocardial infarction (STEMI). Plasma levels of IL6 were measured at 8 time points. The main endpoint was 3 month mortality. Results: We have shown that the highest IL6 levels during the first week were recorded in patients with septic shock with peak value at admission."@en . . . . . "2" . "Jaband\u017Eiev, Petr" . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . . . . "[6B14E4718FC0]" . "Littnerov\u00E1, Simona" . . "RIV/00216224:14110/14:00079379" . "\u00DAvod: Kardiogenn\u00ED \u0161ok (KS) je hlavn\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED pacient\u016F hospitalizovan\u00FDch pro akutn\u00ED infarkt myokardu. V r\u00E1mci akutn\u00EDho infarktu myokardu a kardiogenn\u00EDho \u0161oku byl pozorov\u00E1n rozvoj z\u00E1n\u011Btliv\u00E9 odpov\u011Bdi. C\u00EDlem na\u0161i pr\u00E1ce bylo popsat dynamiku interleukin 6 (IL6) u pacient\u016F v kardiogenn\u00EDm \u0161oku a porovnat ji s dynamikou inter-leukinu 6 u pacient\u016F v septick\u00E9m \u0161oku (S\u0160) a kontroln\u00ED skupinou pacient\u016F s nekomplikovan\u00FDm akutn\u00EDm infarktem myokardu s elevacemi ST (STEMI) a vyhodnotit jeho diagnostick\u00E9 a prognostick\u00E9 mo\u017Enosti. Metodika a pacienti: V prospektivn\u00ED observa\u010Dn\u00ED studii bylo za\u0159azeno celkem 71 pacient\u016F, kte\u0159\u00ED splnili za\u0159azovac\u00ED krit\u00E9ria: 30 pacient\u016F v kardiogenn\u00EDm \u0161oku, 21 pacient\u016F v septick\u00E9m \u0161oku a 20 pacient\u016F se STEMI. Hladiny IL6 byly stanoveny celkem Skr\u00E1t po dobu 3 m\u011Bs\u00EDc\u016F. Hlavn\u00EDm sledovan\u00FDm parametrem byla Sm\u00E9s\u00ED\u010Dn\u00ED mortalita. V\u00FDsledky: Nejvy\u0161\u0161\u00ED hodnoty IL6 byly detekov\u00E1ny v pr\u016Fb\u011Bhu 1. t\u00FDdne u pacient\u016F v septick\u00E9m \u0161oku s maxim\u00E1ln\u00ED hodnotou p\u0159i p\u0159ijet\u00ED." .